MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-30-2023
Apollo Endosurgery Total Liabilities 2011-2026 | APEN
Annual Total Liabilities Apollo Endosurgery
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 77.6 M | 70.3 M | 70.7 M | 72.5 M | 45.6 M | 59.1 M | 59.7 M | 1.08 M | 5.14 M | 5.7 M | 12.2 M | 17.3 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 77.6 M | 1.08 M | 41.4 M |
Quarterly Total Liabilities Apollo Endosurgery
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 73.7 M | - | 70 M | 70.3 M | 71.2 M | 71.7 M | 71.3 M | 70.7 M | 70.7 M | 70.7 M | 70.7 M | 72.5 M | 72.5 M | 72.5 M | 72.5 M | 45.6 M | 45.6 M | 45.6 M | 45.6 M | 59.1 M | 59.1 M | 59.1 M | 59.1 M | 59.7 M | 59.7 M | 59.7 M | 59.7 M | 94 M | 1.08 M | 1.08 M | 1.08 M | 5.14 M | 5.14 M | 5.14 M | 5.14 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 94 M | 1.08 M | 41.7 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Orthofix Medical
OFIX
|
401 M | $ 11.78 | 0.51 % | $ 467 M |  Curacao |
 |
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
Delcath Systems
DCTH
|
12.4 M | $ 9.35 | 4.12 % | $ 335 M | USA |
 |
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | USA |
 |
Penumbra
PEN
|
399 M | $ 335.59 | 0.4 % | $ 13.1 B | USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
24 M | - | -0.97 % | $ 54.4 M | USA |
 |
Insulet Corporation
PODD
|
1.68 B | $ 221.0 | -2.0 % | $ 15.5 B | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
Profound Medical Corp.
PROF
|
12.7 M | $ 5.66 | 9.89 % | $ 180 M |  Canada |
 |
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | USA |
 |
IRadimed Corporation
IRMD
|
14.2 M | $ 101.26 | 0.29 % | $ 1.29 B | USA |
 |
AVITA Medical
RCEL
|
73 M | $ 3.96 | 3.13 % | $ 110 M |  Australia |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
CONMED Corporation
CNMD
|
1.29 B | $ 36.45 | -0.37 % | $ 1.13 B | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Sintx Technologies
SINT
|
6.58 M | $ 2.6 | 1.17 % | $ 7.21 M | USA |
 |
NanoVibronix
NAOV
|
3 M | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
10.6 M | $ 24.7 | - | $ 209 M | USA |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M | Canada |
 |
Smith & Nephew plc
SNN
|
5.09 B | $ 32.29 | 0.39 % | $ 23.8 B |  Britain |
 |
MiMedx Group
MDXG
|
86.1 M | $ 4.11 | -0.61 % | $ 607 M | USA |
 |
Sensus Healthcare
SRTS
|
4.94 M | $ 4.18 | 5.43 % | $ 68.2 M | USA |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
36.3 M | $ 0.67 | -3.71 % | $ 36.5 M | USA |
 |
Aethlon Medical
AEMD
|
2.24 M | $ 2.31 | 6.94 % | $ 3.61 M | USA |
 |
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | USA |
 |
Stryker Corporation
SYK
|
25.4 B | $ 325.47 | -0.95 % | $ 124 B | USA |
 |
Tactile Systems Technology
TCMD
|
55 M | $ 27.52 | 2.46 % | $ 629 M | USA |
 |
InspireMD
NSPR
|
14.2 M | $ 1.79 | - | $ 115 M | Israel |
 |
AdaptHealth Corp.
AHCO
|
2.79 B | $ 11.4 | -0.7 % | $ 1.54 B | USA |
 |
Myomo
MYO
|
27.2 M | $ 0.7 | 0.47 % | $ 29.3 M | USA |
 |
Tandem Diabetes Care
TNDM
|
726 M | $ 24.0 | -2.08 % | $ 1.63 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
20.9 M | $ 2.34 | -2.71 % | $ 137 M | Israel |
 |
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
45.2 M | $ 3.7 | -5.37 % | $ 138 M |  France |
 |
Quanterix Corporation
QTRX
|
123 M | $ 3.94 | 3.14 % | $ 168 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
162 M | $ 16.16 | 1.57 % | $ 379 M | USA |
 |
Outset Medical
OM
|
138 M | $ 3.48 | -1.42 % | $ 52.9 K | USA |